Beat the rise! Delivery fees are going up soon. INFO

Close Notification

Your cart does not contain any items

$76.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
29 May 2013
The Future of Drug Discovery: Who Decides Which Diseases to Treat?
By:   , , , ,
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 229mm,  Width: 152mm,  Spine: 23mm
Weight:   600g
ISBN:   9780124071803
ISBN 10:   0124071805
Pages:   376
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

Founding Editor, TheScientificWorld, CEO, Corpus Alienum Oy, Finland

Reviews for The Future of Drug Discovery: Who Decides Which Diseases to Treat?

""Bartfai and Lees describe the looming crisis in health care.They target society in general as their audience, because of the need for the public to understand what is happening and why they should be concerned. The book is a compendium of data and analysis and there are many tables and figures supporting the text.""--Reference and Research Book News, August 2013 ""A remarkable compendium of hard data and wise prescription for the pharmaceutical industry.""--Michael S. Brown, 1985 Novel Laureate in Medicine or Physiology, UT Southwestern Medical Center ""This is an extraordinary, insightful and provocative book that should be read by all those concerned by the progress of biomedicine, from scientists to politicians."" - Jean-Pierre Changeux, College de France and l'Institut Pasteur ""Bartfai and Lees raise critical issues confronting the search for new medicines. Their analysis is cogent, and their proposals thoughtful and thought provoking. For anyone curious about where new medicines come from, and what it will take for the BioPharma industry to bring new treatments to patients with Alzheimer's disease, diabetes, depression, cancer, and more, this is a must read."" - Michael D. Ehlers, Senior VP Pfizer and CSO Neuroscience, former Howard Hughes Investigator, Duke University ""This book is a must read for students, prescribing physicians, academic and industry researchers, analysts, patient groups, business and science journalists, and importantly, Policy Makers. More than ever before, drug development is a complex scientific, industrial and societal endeavour that needs the combined attention of Governments, Academics and Big Pharma; it cannot be left to Wall Street alone."" - Daniel Hoyer, Chair, Department of Pharmacology, University of Melbourne, former Novartis Leading Scientist


See Also